<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.5281/zenodo.6659389</article-id>
      <article-id pub-id-type="publisher-id">AJPTR122004</article-id>
      <title-group>
        <article-title>Synthesis, Characterization and Biological Evaluation of Some 1,3,4-oxadiazole Incorporated Coumarin Derivatives as Antifungal Agents</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Liton</surname>
            <given-names>Muhammad Abul Kashem</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hasan</surname>
            <given-names>Md. Sajid</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Helen</surname>
            <given-names>Sabrina</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Das</surname>
            <given-names>Mukta</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shalauddin</surname>
            <given-names>Md.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2022-04-01">
        <month>04</month>
        <day>01</day>
        <year>2022</year>
      </pub-date>
      <volume>12</volume>
      <issue>2</issue>
      <abstract>
        <p>Coumarins are the family of benzopyrones, in which benzene ring amalgamated with the pyrone ring. Their versatile oxygen-containing heterocyclic structure and physicochemical characteristics are responsible to attract great attention from medicinal chemists and pharmacologists and for being a privileged scaffold in medicinal chemistry. In this study, 1, 3, 4 -oxadiazole incorporated a series of new coumarin derivatives have been synthesized. Structures of the newly synthesized compounds were established on the basis of FT-IR, 1H NMR spectroscopic techniques and elemental analysis. The synthesized compounds were screened for their in vitro antifungal activity against five pathogenic fungal strains: Aspergillus niger, Penicillium notatum, Saccharomyces cerevisiae, Penicillium chrysogenum and Neurospora crassa by disk-diffusion method. All the compounds were found to have significant antifungal activity against all the fungal strains.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Coumarins</kwd>
        <kwd>1</kwd>
        <kwd>3</kwd>
        <kwd>4-oxadiazole</kwd>
        <kwd>Antifungal Activity.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
